We scan new podcasts and send you the top 5 insights daily.
A lead investor's influence can place startup founders in a difficult position, compelling them to accept investments from controversial sources they might otherwise reject. The example of Curie Bio introducing a portfolio company to Boris Nikolic's fund highlights the power imbalance, where founders may lack the leverage to refuse capital for fear of jeopardizing their primary funding relationship.
A venture capitalist's career security directly impacts the founder relationship. VCs with a proven track record (like Sequoia's Andrew Reed) act as supportive partners. In contrast, junior or less successful VCs often transfer pressure from their own partnerships onto the founder, creating a stressful and counterproductive dynamic.
In today's founder-centric climate, many VCs avoid confrontation to protect their reputation (NPS) within the founder network. This fear of being blacklisted leads them to abdicate their fiduciary duty to shareholders, failing to intervene even when a company's performance is dire and hard decisions are needed.
Unlike in private equity, an early-stage venture investment is a bet on the founder. If an early advisor, IP holder, or previous investor holds significant control, it creates friction and hinders the CEO's ability to execute. QED's experience shows that these situations are untenable and should be avoided.
Despite Boris Nikolic's deep ties to Jeffrey Epstein, his strong financial track record and connections enabled him to raise a $100M fund. This highlights a systemic bias where male VCs with a history of generating returns can overcome severe reputational damage, a privilege often unavailable to female fund managers.
Founders are warned against being manipulated by late-stage investors who pressure them to strip rights (like pro-rata) from early backers. This disloyalty breaks trust and signals to new investors that the founder can also be manipulated, setting a dangerous precedent for future governance.
Beyond product-market fit, there is "Founder-Capital Fit." Some founders thrive with infinite capital, while for others it creates a moral hazard, leading to a loss of focus and an inability to make hard choices. An investor's job is to discern which type of founder they're backing before deploying capital that could inadvertently ruin the company.
While capital is necessary, an overabundance is dangerous. Large secondaries can make founders comfortable and misaligned with investors. Excessive primary capital leads to bloat, unfocused strategy, and removes the pressure that drives invention. This moral hazard often leads to worse outcomes than being capital-constrained.
While multi-stage funds offer deep pockets, securing a new lead investor for later rounds is often strategically better. It provides external validation of the company's valuation, brings fresh perspectives to the board, and adds another powerful, committed firm to the cap table, mitigating signaling risk from the inside investor.
An investor's power over a portfolio company is fundamentally limited and primarily negative. While a VC can block a founder's actions, such as through board approval or withholding capital, they cannot force a founder to take a specific path, even if it seems obviously correct. The role is to advise and assist, not to command or execute.
Prominent VC Alexis Borisi backed Boris Nikolic's new fund based on personal loyalty and trust, despite public red flags about Nikolic's ties to Jeffrey Epstein. Borisi's vouching acted as a 'cosigner', enabling Nikolic to raise $100M. This demonstrates how personal relationships in venture capital can supersede standard reputational due diligence, creating significant downstream risk for LPs and portfolio companies.